Cerity Partners
KRRO icon

Cerity Partners’s Korro Bio KRRO Stock Holding History

Cerity Partners’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$142K Buy
+10,794
New +$134K ﹤0.01% 3152
2021
Q2 		– Sell
-200
Closed -$95K – 725
2021
Q1 		$95K Hold
200
– – ﹤0.01% 682
2020
Q4 		$353K Hold
200
– – 0.01% 481
2020
Q3 		$192K Hold
200
– – 0.01% 469
2020
Q2 		$233K Buy
+200
New +$181K 0.01% 392

Other funds holding KRRO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Cerity Partners's KRRO Position: Q2 2026 in Review

Cerity Partners opened a new position in Korro Bio (KRRO) in Q2 2026: 10,794 shares worth $142K. The stake represents ﹤0.01% of the portfolio and ranks #3152 among its holdings. This is a return to the name: Cerity Partners previously reported a position in KRRO as recently as Q1 2021.

Cerity Partners first reported a position in KRRO in Q2 2020 and has held it in 5 quarters since. The position peaked at $353K in Q4 2020. 107 funds tracked by Wall St. Rank hold KRRO as of Q2 2026.

  • Cerity Partners held 10,794 shares of Korro Bio worth $142K as of Q2 2026.
  • Korro Bio was a new Cerity Partners position in Q2 2026.
  • Korro Bio made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #3152 holding.
  • Cerity Partners first reported a position in Korro Bio in Q2 2020 and has held it in 5 quarters since.
  • Cerity Partners's Korro Bio position peaked at $353K in Q4 2020.
  • 107 funds tracked by Wall St. Rank held Korro Bio as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.